FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Maria Staykova

Research Profile

Disorders

Living Beings

Anatomy

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
Filomena Mattner; Tien Pham; Mitchell Quinlivan; Maria A Staykova; David O Willenborg; Patrice Ballantyne; David Linares Bandin; Paula Berghofer; Sue Fordham; Marie Claude Gregoire; Andrew Katsifis
Evaluation of [¹²³I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation.
Paula Maña; Sue Fordham; Maria A Staykova; Manuel Correcha; Diego Silva; David O Willenborg; David Liñares
Demyelination caused by the copper chelator cuprizone halts T cell mediated autoimmune neuroinflammation.
Maria A Staykova; David Liñares; Sue Fordham; Judith T Paridaen; David O Willenborg
The innate immune response to adjuvants dictates the adaptive immune response to autoantigens.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Maria Staykova (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Filomena Mattner; Tien Pham; Mitchell Quinlivan; Maria A Staykova; David O Willenborg; Patrice Ballantyne; David Linares Bandin; Paula Berghofer; Sue Fordham; Marie Claude Gregoire; Andrew Katsifis
Evaluation of [¹²³I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation.
European journal of nuclear medicine and molecular imaging 2011;38(8):1516-28.
2009: Paula Maña; Sue Fordham; Maria A Staykova; Manuel Correcha; Diego Silva; David O Willenborg; David Liñares
Demyelination caused by the copper chelator cuprizone halts T cell mediated autoimmune neuroinflammation.
Journal of neuroimmunology 2009;210(1-2):13-21.
2008: Maria A Staykova; David Liñares; Sue Fordham; Judith T Paridaen; David O Willenborg
The innate immune response to adjuvants dictates the adaptive immune response to autoantigens.
Journal of neuropathology and experimental neurology 2008;67(6):543-54.
2007: David O Willenborg; Maria A Staykova
Reglation of neuroinflammation.
Journal of neuroimmunology 2007;191(1-2):1.
2007: David O Willenborg; Maria A Staykova; Sue Fordham; Nikki O'Brien; David Linares
The contribution of nitric oxide and interferon gamma to the regulation of the neuro-inflammation in experimental autoimmune encephalomyelitis.
Journal of neuroimmunology 2007;191(1-2):16-25.
2007: Amanda M de Mestre; Maria A Staykova; June R Hornby; David O Willenborg; Mark D Hulett
Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.
Journal of leukocyte biology 2007;82(5):1289-300.
2006: David Liñares; Maaike Taconis; Paula Maña; Manuel Correcha; Sue Fordham; Maria A Staykova; David O Willenborg
Neuronal nitric oxide synthase plays a key role in CNS demyelination.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(49):12672-81.
2006: Maria A Staykova; Sue Fordham; Gavin J Bartell; William B Cowden; David O Willenborg
Nitric oxide contributes to the resistance of young SJL/J mice to experimental autoimmune encephalomyelitis.
Journal of neuroimmunology 2006;176(1-2):1-8.
2006: Paula Maña; David Liñares; Sue Fordham; Maria A Staykova; David O Willenborg
Deleterious role of IFNgamma in a toxic model of central nervous system demyelination.
The American journal of pathology 2006;168(5):1464-73.
2005: Filomena Mattner; Andrew Katsifis; Maria A Staykova; Patrice Ballantyne; David O Willenborg
Evaluation of a radiolabelled peripheral benzodiazepine receptor ligand in the central nervous system inflammation of experimental autoimmune encephalomyelitis: a possible probe for imaging multiple sclerosis.
European journal of nuclear medicine and molecular imaging 2005;32(5):557-63.
2005: Maria A Staykova; Judith T Paridaen; William B Cowden; David O Willenborg
Nitric oxide contributes to resistance of the Brown Norway rat to experimental autoimmune encephalomyelitis.
The American journal of pathology 2005;166(1):147-57.
2004: Shaun R McColl; Surendran Mahalingam; Maria A Staykova; Laurie A Tylaska; Katherine E Fisher; Christine A Strick; Ronald P Gladue; Kuldeep S Neote; David O Willenborg
Expression of rat I-TAC/CXCL11/SCYA11 during central nervous system inflammation: comparison with other CXCR3 ligands.
Laboratory investigation; a journal of technical methods and pathology 2004;84(11):1418-29.
2003: Amanda M de Mestre; Levon M Khachigian; Fernando Santos Santiago; Maria A Staykova; Mark D Hulett
Regulation of inducible heparanase gene transcription in activated T cells by early growth response 1.
The Journal of biological chemistry 2003;278(50):50377-85.
2003: Maria A Staykova; Leise A Berven; William B Cowden; David O Willenborg; Michael F Crouch
Nitric oxide induces polarization of actin in encephalitogenic T cells and inhibits their in vitro trans-endothelial migration in a p70S6 kinase-independent manner.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(10):1337-9.
2003: David O Willenborg; Maria A Staykova
Cytokines in the pathogenesis and therapy of autoimmune encephalomyelitis and multiple sclerosis.
Advances in experimental medicine and biology 2003;520():96-119.
2002: Maria A Staykova; William B Cowden; David O Willenborg
Macrophages and nitric oxide as the possible cellular and molecular basis for strain and gender differences in susceptibility to autoimmune central nervous system inflammation.
Immunology and cell biology 2002;80(2):188-97.
2001: E J Hindmarsh; Maria A Staykova; David O Willenborg; Christopher R Parish
Cell surface expression of the 300 kDa mannose-6-phosphate receptor by activated T lymphocytes.
Immunology and cell biology 2001;79(5):436-43.
2000: Maria A Staykova; L Maxwell; David O Willenborg
Kinetics and polarization of the membrane expression of cytokine-induced ICAM-1 on rat brain endothelial cells.
Journal of neuropathology and experimental neurology 2000;59(2):120-8.
1999: David O Willenborg; Maria A Staykova; William B Cowden
Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review.
Journal of neuroimmunology 1999;100(1-2):21-35.
1999: David O Willenborg; Sue Fordham; Maria A Staykova; Ian A Ramshaw; William B Cowden
IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(10):5278-86.
1998: Shaun R McColl; Maria A Staykova; A Wozniak; Sue Fordham; J Bruce; David O Willenborg
Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(11):6421-6.
1998: William B Cowden; F A Cullen; Maria A Staykova; David O Willenborg
Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE.
Journal of neuroimmunology 1998;88(1-2):1-8.
1998: Christopher R Parish; E J Hindmarsh; M R Bartlett; Maria A Staykova; William B Cowden; David O Willenborg
Treatment of central nervous system inflammation with inhibitors of basement membrane degradation.
Immunology and cell biology 1998;76(1):104-13.
1998: David O Willenborg; Maria A Staykova
Approaches to the treatment of central nervous system autoimmune disease using specific neuroantigen.
Immunology and cell biology 1998;76(1):91-103.
1997: Maria A Staykova; R D Simmons; David O Willenborg
Infusion of soluble myelin basic protein protects long-term against induction of experimental autoimmune encephalomyelitis.
Immunology and cell biology 1997;75(1):54-64.
1996: David O Willenborg; Maria A Staykova; M Miyasaka
Short term treatment with soluble neuroantigen and anti-CD11a (LFA-1) protects rats against autoimmune encephalomyelitis: treatment abrogates autoimmune disease but not autoimmunity.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(5):1973-80.